Envision Healthcare Holdings, Inc. 4
4 · Envision Healthcare Holdings, Inc. · Filed Dec 1, 2016
Insider Transaction Report
Form 4
Packard Dighton
Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
2016-12-01−431→ 0 total - Disposition to Issuer
Option (Right to buy)
2016-12-01−11,418→ 0 totalExercise: $21.99Exp: 2026-02-24→ Common Stock (11,418 underlying) - Disposition to Issuer
Option (Right to buy)
2016-12-01−207,354→ 0 totalExercise: $3.69Exp: 2021-05-22→ Common Stock (207,354 underlying) - Disposition to Issuer
Option (Right to buy)
2016-12-01−1,390→ 0 totalExercise: $38.60Exp: 2025-03-20→ Common Stock (1,390 underlying)
Footnotes (4)
- [F1]Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.
- [F2]Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
- [F3]Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst stock option having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
- [F4]These stock options are scheduled to vest in three installments on each of the first three anniversaries of February 24, 2016, subject to the Reporting Person's continued employment.